Highlights
- •Duration of (p)rehabilitation in published studies may have been too short to achieve effects on HRQoL
- •There is heterogeneity of both physical exercise training programs and outcomes used to assess HRQoL
- •At least 4 weeks of moderate or high-intensity (p)rehabilitation seems to improve HRQoL
Abstract
Background
Methods
Results
Conclusion
Keywords
1. Introduction
Netherlands Cancer Registry: Meest voorkomende lokalisaties van kanker in 2020. http://cijfersoverkanker.nl. Accessed March 30, 2021.
Netherlands Cancer Registry: Incidence of Lung Cancer in The Netherlands according to type of histology. Available from: http://cijfersoverkanker.nl. Accessed March 30, 2021.
Netherlands Cancer Registry: Richtlijn niet-kleincellig longcarcinoom. Published 2004. Updated June 3, 2020. Available from: http://cijfersoverkanker.nl. Accessed March 30, 2021.
Incidence of non-small cell lung cancer in The Netherlands in 2021 according to 5-year age groups Available from.
- Driessen E.J.M.
- Bootsma G.P.
- Hendriks L.E.L.
- van den Berkmortel F.W.P.J.
- Bogaarts B.A.H.A.
- van Loon J.G.M.
- et al.
- Steffens D.
- Beckenkamp P.R.
- Hancock M.
- Solomon M.
- Young J.
- Driessen E.J.
- Peeters M.E.
- Bongers B.C.
- Maas H.A.
- Bootsma G.P.
- van Meeteren N.L.
- et al.
2. Methods
2.1 Data sources and searches
2.2 Study selection
2.3 Assessment of methodological quality
2.4 Therapeutic quality
Low risk of ineffectiveness | High risk of ineffectiveness | |
---|---|---|
1. Patient selection | A VO2peak < 20 mL/kg/min and/or a predicted postoperative VO2peak < 10 mL/kg/min for prehabilitation or other selection criteria with a clear rationale for prehabilitation and/or rehabilitation. | No preselection or selection (described). |
2. Dosage of the exercise program | Intensity and duration of the physical exercise training program must be clearly described and/or based on existing literature relevant to the target population of operable patients with NSCLC and/or an adequate exercise test (e.g., steep ramp test, CPET). | Intensity and duration of the physical exercise training program is not (adequately) described and/or no physiological improvement can be expected due to a low training dosage (frequency, intensity, time). |
3. Type of the exercise program | At least aerobic training with or without resistance training. | An intervention inconsistent with the goal of training therapy for patients undergoing surgery for lung cancer. |
4. Qualified supervisor (if applicable) | Guidance of a physical therapist who is specialized in supervising adult clinical populations. | Supervision or guidance is not reported or supervision or guidance was provided by a professional other than a physical therapist. |
5. Type and timing of outcome assessment | Follow-up for HRQoL and/or fatigue before and after exercise prehabilitation and/or before and after exercise rehabilitation. | Follow-up for HRQoL and/or fatigue was not clearly described. |
6. Safety of the exercise program | Adverse events related to the exercise program are described and acceptable as would be expected in the studied population. | Adverse events related to the exercise program are higher than would be expected in the studied population or adverse events were not described. |
7. Adherence to the exercise program | Adherence was determined separately for training frequency and deemed good in case of ≥80%. | Adherence to the training frequency was <80%. |
2.5 Data extraction
3. Results
3.1 Study characteristics
3.1.1 Study selection
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.

First author, year | Number of participants, n Study design Intervention | Stage of disease, n | Mean age, year, ±SD (range) | Comorbidity, n | Type of surgery, n | Outcome measures |
---|---|---|---|---|---|---|
Exercise prehabilitation | ||||||
Coats [ [23] ], 2013 | • 13 • Prospective cohort • Aerobic exercises, resistance exercises | • I: 5 II: 4 IV: 2 Unknown: 2 | 59 ± 9 | • COPD: 5 (38%) | • Awaiting surgery: 10 • CT: 1 • Postoperative palliative CT: 1 • Postoperative palliative RT and CT: 1 | • HRQoL • Fatigue |
Huang [ [25] ], 2017 | • IG: 30, UC: 30 • RCT • Aerobic exercises, breathing exercises | • I: IG: 16, UC: 17 II: IG: 10, UC: 11 III: IG: 4, UC: 2 | IG: 63.0 ± 8.7 UC: 63.6 ± 6.5 | • ASA score >3: IG: 3 (10%), UC: 2 (7%), p = 1.00 • COPD: IG: 5 (17%), UC: 2 (7%), p = 0.49 | • VATS: IG: 17, UC: 9 • Open surgery: IG: 13, UC: 11 | • HRQoL • Fatigue |
Lai [ [28] ],2016 | • IG: 30, UC: 30 • RCT | • I: IG: 16, UC: 18 II: IG: 10, UC: 10 III: IG: 3, UC: 2 IV: IG: 1, UC: 0 | IG: 72.5, ±3.4 UC: 71.6, ±1.9 p = 0.23 | • ASA score: IG: 3 (10%) UC: 3 (10%) (p 1.00) • COPD: IG: 5 (17%) UC: 4 (13%), p = 1.00 | • VATS: IG: 21, UC: 20 • Open surgery: IG: 9, UC: 10 | • HRQoL |
Lai [ [29] ], 2017 | • IG: 51, UC: 50 • RCT • Aerobic exercises, breathing exercises | • I: IG: 30, UC: 20 II: IG: 14, UC: 25 III: IG: 6, UC: 5 IV: IG: 1, UC: 0 | IG: 63.8 ± 8.2 UC: 64.6 ± 6.6 p = 0.58 | • Charlson comorbidity index 0–2: IG: 32 (63%), UC: 43 (86%), p = 1.00 • Charlson comorbidity ≥3: IG 18 (35%), UC: 7 (14%), p = 1.00 | • VATS: IG: 32, UC: 34 • Open surgery: IG: 19, UC: 16 | • HRQoL • COPD: IG: 9 (28%), UC: 11 (34%), p = 0.61 |
Lai [ [30] ], 2019 | • IG: 32, UC: 32 • RCT • Aerobic exercises, breathing exercises | • I: NR | IG: 64.2 ± 6.8 UC: 63.4 ± 8.2 p = 0.67 | • Hypertension: IG: 8 (25%), UC: 3 (9%), p = 1.00 • DM II: IG: 3 (9%), UC: 1 (3%), p = 0.61 | • VATS | • HRQoL • Fatigue |
Peddle [ [21] ], 2009 | • 9 • Prospective cohort • Aerobic exercises, resistance exercises, breathing exercises | • NSCLC: 6 Kidney: 1 Hamartoma: 1 Spindle cell sarcoma: 1 | 64 ± 8 p = NR | • COPD: 3 (33%) • Charlson comorbidity index >3: (100%) | • Lobectomy: 6 • Pneumonectomy: 1 • Wedge resection: 2 | • HRQoL • Fatigue |
Sebio Garcia [ [22] ], 2017 | • IG: 10, UC: 12 • RCT • Aerobic exercises, resistance exercises, breathing exercises | • NR | IG: 69.4 ± 9.4 UC: 70.9 ± 6.1 | • Respiratory disease: IG: 7 (70%), UC: 4 (33%), p = NR • Cardiovascular disease: IG: 8 (80%), UC: 9 (75%), p = NR • DM II: IG: (10%), UC: 1 (8%), p = NR | • VATS | • HRQoL |
Tenconi [ [33] ], 2021 | • IG: 70, UC: 70 • RCT • Aerobic exercises, resistance exercises, breathing exercises, therapeutic education | • I and II: NR | IG: 66.0 ± 10.6 UC: 67.7 ± 10.8 p = NR | • NR | • VATS • RATS | • HRQoL |
Exercise rehabilitation | ||||||
Jastrzebski [ [26] ], 2018 | • IG: 22, UC: 21 • RCT • Aerobic exercises, resistance exercises, breathing exercises | • NR | IG: 69.8 ± 6.0 UC: 69.0 (±9.6) p = NR | • NR | • Lobectomy | • HRQoL |
Lu [ [31] ], 2020 | • 16 • Prospective cohort • Aerobic exercises, resistance exercises, Tai-Chi | • I, II, and IIIa: NR | 59 (44–63) p = NR | • NR | • Lobectomy: 8 • Wedge resection: 3 • Segmentectomy: 2 • Lobectomy and wedge resection: 3 • Segmentectomy and wedge resection: 1 | • HRQoL • Fatigue |
Messagi-Sartor [ [32] ], 2019
Combined aerobic exercise and high-intensity respiratory muscle training in patients surgically treated for non-small cell lung cancer: a pilot randomized clinical trial. Eur J Phys Rehabil Med. 2018; 55: 113-122 | • IG: 16, UC: 21 • RCT • Aerobic exercises, breathing exercises | • I and II: NR | IG: 64.2 ± 8.1 UC: 64.8 ± 8.9 p > 0.05 | • COPD (27%): IG: NR, UC: NR | • VATS: IG: 2, UC: 1 • Thoracotomy: IG: 14 UC: 20 | • HRQoL • Fatigue |
Combination of exercise prehabilitation and exercise rehabilitation | ||||||
Granger [ [24] ], 2018 | • 37 • Prospective cohort • Aerobic exercises, resistance exercises | • I: 22 II: 5 III: 2 IV: 3 Unknown: 5 | 62.7 ± 10.5 P=NR | • NR | • Lobectomy: 20 • Wedge resection: 10 • Segmentectomy: 3 • Pneumonectomy: 2 • Other: 2 | • HRQoL • Fatigue |
Kadiri [ [27] ], 2019 | • 31 • Prospective cohort • Aerobic exercises, resistance exercises | • NSCLC: 17 Stage IV NSCLC: 1 Other lung cancer type: 7 Benign: 6 | 64 ± 12 | • Ischemic heart disease: 2 (6%) • COPD: 9 (29%) | • NR | • HRQoL • Fatigue |
3.1.2 Exercise prehabilitation and rehabilitation
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
First author, year | Patient selection |
| Qualified supervisor | Primary outcome of the study Type and timing of outcome assessment | Safety |
---|---|---|---|---|---|
Exercise prehabilitation | |||||
Coats [ [23] ], 2013 | 45–80 years, SpO2 <80% during CPET, comorbidities | • Based on: NR • Program duration: 4 weeks Aerobic exercises: F: 3–5/week, I: 60–80% of CPET WRpeak, with reduction of intensity in case of a 1–10 Borg dyspnea scores ≥6, T: 30 min, T: Cycle ergometer Resistance exercises: F: 3–5/week, I: 2–3 kg, progressively increasing, T: 2 × 10–15 repetitions, T: gravity-resisted exercises | Consult by phone by the researchers | • HRQoL • HRQoL and fatigue: at baseline and after four weeks (before surgery) | No adverse events |
Huang [ [25] ], 2017 | >70 years, BMI >30, COPD with heavy smoking history, FEV1/FVC ratio ≤70% | • Based on: NR • Program duration: 1 week Aerobic exercises: F: 7/week, I: Own speed and power, progressively increased the resistance range, T: 20 min, T: cross-trainer Breathing exercises: F: 2–3/day, I: NR, T: 15–20, T: threshold inspiratory muscle trainer | Trained nurses | • Postoperative pulmonary complications • HRQoL and fatigue: at baseline and after one week (before surgery) | NR |
Lai [ [28] ],2016 | ≥70 years | • Based on: NR • Program duration: 1 week Aerobic exercises: F: 1/day, I: self-preferred speed and power, T: 30 min, T: cross-trainer | Aerobic exercises supervised by a physical therapist | • Change in 6MWD • HRQoL: at baseline and after one week (before surgery) | NR |
Lai [ [29] ] 2017 | >75 years, >20 pack-year smoking history, BMI >30 kg/m2, ppoFEV1 <60%, ppoDLCO <60%, COPD | • Based on: NR • Program duration: 1 week Aerobic exercises: F: 1/day, I: not clearly reported, T: 30 min, T: cross-trainer Breathing exercises: F: 2–3/day, I: NR, T: 15–20 min, T: threshold inspiratory muscle trainer and manual deep breathing exercises | Physical therapist dedicated to thoracic surgery patients | • Postoperative pulmonary complications • HRQoL: at baseline and after one week (before surgery) | No adverse events |
Lai [ [30] ] 2019 | 45–80 years and ppoFEV1 <60% | • Based on: NR • Program duration: 1 week Aerobic exercises: F: 7/week, I: NR, T: 30 min, T: cross-trainer Breathing exercises: F: 3/day, I: NR, T: 20 breaths/session, T: threshold inspiratory muscle trainer | Aerobic exercises supervised by a physical therapist, respiratory exercises supervised by a trained nurse | • Postoperative pulmonary complications • HRQoL and fatigue: at baseline and after one week (before surgery) | No adverse events |
Peddle [ [21] ], 2009 | ≥18 years | • Based on: NR • Program duration: NR Aerobic exercises: F: 5/week, I-T: week 1: increasing duration and intensity from 20 min at 60% of CPET VO2peak to 30 min at 65% of CPET VO2peak, weeks 2 and 3: 4 sessions of 25–30 min at 60–65% of CPET VO2peak and 1 session of 20 min at the ventilatory anaerobic threshold. After week 3: 3 sessions of 60–65% of CPET VO2peak for 30–35 min, 1 threshold workout, and 1 interval workout per week, T: cycle ergometer | Exercise physiologist | • HRQoL and fatigue • HRQoL and fatigue: at baseline and after prehabilitation (before surgery) | No adverse events |
Sebio Garcia [ [22] ], 2017 | ≥18 years, at least one of the following: (a) FEV1 ≤80% of predicted value or BMI ≥30 or age ≥75 years or two or more co-morbidities identified in the Colinet Comorbidity Score | • Based on [ [40] ]• Program duration: NR Aerobic exercises: F: 3–5/week, I: interval training (1 min at high intensity (80% of CPET WRpeak) plus 4 min of active rest (performed at 50% of CPET WRpeak), T: 30 min, T: cycling Resistance exercises: F: 3–5/week, I: 25 repetition maximum test, T: 3 × 15 repetitions, T: six exercises using Thera bands and body mass for the large muscle groups Breathing exercises: F: 2/day, I: 80% of vital capacity, T: 6 cycles of 5 repetitions, T: incentive spirometry coach2 | Physical therapist | • HRQoL • HRQoL: at baseline and after prehabilitation (before surgery) | No adverse events |
Tenconi [ [33] ], 2021 | All patients | • Based on [ [41] ]• Program duration: 2–3 weeks Aerobic exercises: F: 2–3/week, I: NR, T: 30–40 min, T: at the outpatient clinic: cycling; home-based: walking Resistance exercises: F: 2–3/week, I: maximal load (previously determined with the 10-repetition maximum test), T: 2–3 sets of 10 repetitions, T: lower limbs (extensor muscle group), upper limbs (biceps, triceps, deltoids, latissimus dorsi, pectoralis), and abdominal wall Breathing exercises: F: 1/day, I: ≥30% of maximal predicted inspiratory pressure and adapted to the patient's tolerance, T: 15–30 min, T: threshold inspiratory muscle trainer | Physical therapist | • Change in 6MWD • HRQoL: at baseline and 6 months after surgery | Adverse events: IG: 2 (7%): mild, 17 (55%): moderate, 11 (37%): severe, UC: 2 (4%): mild, 37 (69%): moderate, 15 (28%): severe |
Exercise rehabilitation | |||||
Jastrzebski [ [26] ], 2018 | ECOG 0-1 | • Based on: NR • Program duration: 2 weeks, 10 (±4) weeks after surgery Aerobic exercises: F: 5/week, I: 30–80% of HRpeak, T: 20–30 min, T: cycle ergometer or treadmill Resistance exercises: F: 5/week, I: 40–70% of 1RM, T: NR, T: Nordic walking Breathing exercises: F: 5/week, I: NR, T: 30, T: breathing, a prolonged exhalation exercise, and chest percussion | NR | • Change in 6MWD and HRQoL • HRQoL: at the first day of exercise rehabilitation and after exercise rehabilitation at day 21 | Minor adverse events: arthritis: n = 1, knee pain: n = 2 |
Lu [ [31] ], 2020 | 18–75 years, ECOG 0-2 | • Based on: NR • Program duration: 12 weeks, 6–12 weeks after surgery Aerobic exercises: F: 2/week, I: 15 min on 80% of baseline mean walk speed on the 6MWT and increased at moderate intensity (Borg-score 4–10, somewhat hard), T: 90 min, T: treadmill Resistance exercises: F: NR, I: Borg-score 4–10, somewhat hard, T: 3 sets of 8–15 repetitions, T: major limb movement | Specialized physical therapist | • Feasibility and safety of delivering rehabilitation • HRQoL and fatigue: at the start of exercise prehabilitation and after exercise rehabilitation at 12 weeks | No adverse events |
Messagi-Sartor [ [32] ], 2019
Combined aerobic exercise and high-intensity respiratory muscle training in patients surgically treated for non-small cell lung cancer: a pilot randomized clinical trial. Eur J Phys Rehabil Med. 2018; 55: 113-122 | <80 year | • Based on: NR • Program duration: 8 weeks, 6 weeks after surgery Aerobic exercises: F: 3/week, I: 60% of baseline WRpeak on the CPET, T: 30 min, T: cycle ergometer Breathing exercises: F: 3/week, 2/day, I: 50% of PImax and PEmax and adjusted weekly by 10 cm cm H2O, T: 5 sets of 10 repetitions, T: inspiratory and expiratory muscle trainer | Physical therapist | • HRQoL • HRQoL and fatigue: at the start of exercise rehabilitation and after exercise rehabilitation at 8 weeks | No adverse events |
Combination of exercise prehabilitation and rehabilitation | |||||
Granger [ [24] ] | ≥18 years | • Based on: NR • Program duration: 9 weeks: ≤7 days preoperative and until 8 weeks postoperative Aerobic exercises: F: 5/week, I: moderate, T: 30 min, T: walking Resistance exercises: F: 3/week, I: moderate (1–10 Borg dyspnea scale 4–6, somewhat hard), T: 2 sets of 10–15 repetitions, T: major muscle groups | Specialized physical therapist | • Feasibility and safety of delivering prehabilitation and rehabilitation • HRQoL and fatigue: at baseline before prehabilitation (before surgery) and at 8 weeks after rehabilitation (after surgery) | No adverse events |
Kadiri [ [27] ], 2019 | All patients | • Based on [ [42] ]• Program duration: NR Aerobic exercises F: 1/day, I: a target heart rate (>60% of maximum heart rate), T: at least 20 min, T: walking, swimming, exercise classes or cycling Resistance exercises: F: 1/day, I: a target heart rate (>60% of maximum heart rate), T: 10 × 3 min per exercise, T: upper and lower limb | Physical therapist | • Postoperative pulmonary complications and length of hospital stay • HRQoL and fatigue: at baseline (before surgery) and 6 weeks after rehabilitation (after surgery) | No adverse events |
3.1.3 Methodological quality
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
Methodological quality (Cochrane risk of bias tool) | ||||||||
---|---|---|---|---|---|---|---|---|
First author | Randomization process | Assignment to intended interventions | Adherence to intended interventions | Missing outcome data | Measurement of the outcome | Selection of the reported result | Overall risk of bias | |
Exercise prehabilitation | ||||||||
Huang [ [25] ] | Low | Low | Low | Low | Low | Low | Low | |
Lai [ [28] ] | Some | Low | High | Low | Low | Low | Some | |
Lai [ [29] ] | Low | High | High | Low | Low | Low | Low | |
Lai [ [30] ] | Some | Some | High | Low | Low | Low | Some | |
Sebio Garcia [ [22] ] | Some | High | Low | High | Low | Low | Some | |
Tenconi [ [33] ] | Some | Some | Some | Low | Low | Some | Some | |
Exercise rehabilitation | ||||||||
Jastrzebski [ [26] ] | High | Low | High | high | High | High | High | |
Messagi-Sartor [ [32] ]
Combined aerobic exercise and high-intensity respiratory muscle training in patients surgically treated for non-small cell lung cancer: a pilot randomized clinical trial. Eur J Phys Rehabil Med. 2018; 55: 113-122 | Low | Low | High | Low | Low | Low | Low | |
Methodological quality (Robins-1 tool) | ||||||||
First author | Confounding | Selection | Intervention classification | Deviation from interventions | Missing outcome data | Measurement of outcome | Selection of reported results | Overall risk of bias |
Exercise prehabilitation | ||||||||
Coats [ [23] ] | Moderate | Low | Moderate | Low | Low | Low | Low | Moderate |
Peddle [ [21] ] | Moderate | Moderate | Moderate | Low | Low | Low | Moderate | Serious |
Exercise rehabilitation | ||||||||
Lu [ [31] ] | Moderate | Moderate | Moderate | Low | Low | Low | Low | Moderate |
Combination of exercise prehabilitation and rehabilitation | ||||||||
Granger [ [24] ] | Moderate | Moderate | Moderate | Low | Low | Low | Low | Moderate |
Kadiri [ [27] ] | Moderate | No information | Moderate | Low | Low | Low | Low | Moderate |
Therapeutic quality (i-CONTENT scale)a | ||||||||
First author | 1. Patient selection | 2. Dosage of the exercise program | 3. Type of the exercise program | 4. Qualified supervisor (if applicable) | 5. Type and timing of outcome assessment | 6. Safety of the exercise program | 7. Adherence to the exercise program | Overall risk of ineffectiveness |
Exercise prehabilitation | ||||||||
Coats [ [23] ] | High | High | High | Low | High | High | High | High |
Huang [ [25] ] | Low | High | Low | Low | Low | Low | Low | Some |
Lai [ [28] ] | High | High | Low | Low | High | Low | Low | High |
Lai [ [29] ] | Low | High | Low | Low | High | Low | Low | Some |
Lai [ [30] ] | High | High | Low | Low | High | Low | Low | High |
Peddle [ [21] ] | High | High | High | High | Low | High | High | High |
Sebio Garcia [ [22] ] | High | High | High | High | High | High | Low | High |
Tenconi [ [33] ] | High | Low | Low | Low | Low | Low | Low | Some |
Exercise rehabilitation | ||||||||
Jastrzebski [ [26] ] | High | High | High | Low | High | Low | Low | High |
Lu [ [31] ] | High | High | Low | Low | High | Low | Low | High |
Messagi-Sartor [ [32] ]
Combined aerobic exercise and high-intensity respiratory muscle training in patients surgically treated for non-small cell lung cancer: a pilot randomized clinical trial. Eur J Phys Rehabil Med. 2018; 55: 113-122 | Low | Low | Low | Low | Low | Low | High | Some |
Combination of exercise prehabilitation and exercise rehabilitation | ||||||||
Granger [ [24] ] | High | High | High | High | High | High | High | High |
Kadiri [ [27] ] | Low | High | High | High | High | Low | High | High |
3.1.4 Therapeutic quality
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
3.2 Health-related quality of life and fatigue
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
Author, year | Risk of bias Risk of ineffectiveness | Exercise intervention | Outcomes on quality of life and/or fatigue | Non-participation in the study Drop-outs Training adherence | ||
---|---|---|---|---|---|---|
Aerobic exercises | Resistance exercises | Breathing exercises | ||||
Exercise prehabilitation | ||||||
Coats [ [23] ], 2013, Prospective cohort |
| • | • | HRQoL: EORTC-QLQ-C30 No statistically significant improvement Fatigue: EORTC-QLQ-C30 fatigue subscale No statistically but a clinically significant reduction |
| |
Huang [ [25] ], 2017, RCT |
| • | • | HRQoL: EORTC-QLQ-C30 A statistically significant improvement in the IG compared to UC, p=0.04 Fatigue: fatigue index No statistically significant reduction in the IG compared to UC |
| |
Lai [ [28] ],2016, RCT |
| • | HRQoL: EORTC-QLQ-C30 No statistically significant increase was observed in the IG compared to UC |
| ||
Lai [ [29] ] 2017, RCT |
| • | • | HRQoL: EORTC QLQ-C30 No statistically significant increase was observed in the IG compared to UC |
| |
Lai [ [30] ] 2019, RCT |
| • | • | HRQoL: EORTC QLQ-C30 A statistically significant improvement in emotional function in the IG compared to UC, p<0.01 Fatigue: fatigue index No statistically significant reduction in the IG compared to UC |
| |
Peddle [ [21] ], 2009, prospective observational |
| • | HRQoL: FACT-L A statistically significant improvement in the lung cancer subscale after prehabilitation compared with baseline, p<0.01 Fatigue: FACT subscale for fatigue No statistically significant reduction after prehabilitation compared with baseline |
| ||
Sebio Garcia [ [22] ], 2017, RCT |
| • | HRQoL: SF-36 A statistically significant improvement in the physical component summary in the IG compared to the UC, p<0.01 |
| ||
Tenconi [ [33] ], 2021, RCT |
| • | • | HRQoL: SF-12 No statistically significant improvement in the IG compared to UC |
| |
Exercise rehabilitation | ||||||
Jastrzebski [ [26] ], 2018, RCT |
| • | • | • | HRQoL: SF-36 A statistically significant improvement within the IG and/or UC on the subscales: Pain: IG: p=0.04, UC: p<0.01 Physical functioning: IG: p=0.02 Physical health: IG: p = 0.05 General health: IG: p<0.01 Vitality: UC: p=0.02 Mental health: UC: p<0.01 |
|
Lu [ [31] ], 2020 prospective cohort |
| • | • | HRQoL: EORTC QLQ-C30 A statistically significant improvement on emotional function compared with before rehabilitation, p<0.01 Fatigue: EORTC-QLQ-C30 fatigue subscale No statistically significant reduction compared with before rehabilitation |
| |
Messagi-Sartor [ [32] ], 2019, RCT
Combined aerobic exercise and high-intensity respiratory muscle training in patients surgically treated for non-small cell lung cancer: a pilot randomized clinical trial. Eur J Phys Rehabil Med. 2018; 55: 113-122 |
| • | • | HRQoL: EORTC-QLQ-30 No statistically significant difference between the IG and UC A clinically significant improvement within the IG and UC Fatigue: EORTC-QLQ-C30 fatigue subscale No statistically significant reduction between the IG and UC |
| |
Combination of exercise prehabilitation and exercise rehabilitation | ||||||
Granger [ [24] ], 2018, prospective cohort |
| • | • | HRQoL: EORTC-QLQ-30 No statistically significance improvement Fatigue: EORTC-QLQ-C30 fatigue subscale No statistically significant reduction |
| |
Kadiri [ [27] ], 2019, prospective cohort |
| • | • | HRQoL: EORTC-QLQ-30 A statistically significant improvement at 5 months postoperative compared with preoperative Fatigue: EORTC-QLQ-C30 fatigue subscale No statistically significant reduction |
|
3.2.1 Exercise prehabilitation
3.2.2 Exercise rehabilitation
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
- Messaggi-Sartor M.
- Marco E.
- Martinez-Tellez E.
- Rodriguez-Fuster A.
- Palomares C.
- Chiarella S.
- et al.
3.2.3 Combination of exercise prehabilitation and rehabilitation
4. Discussion
4.1 Strengths and limitations
5. Conclusion
Funding statement
Author contribution statement
Data availability statement
Declaration of competing interest
Appendix A. Supplementary data
- Multimedia component 1
References
Netherlands Cancer Registry: Meest voorkomende lokalisaties van kanker in 2020. http://cijfersoverkanker.nl. Accessed March 30, 2021.
Netherlands Cancer Registry: Incidence of Lung Cancer in The Netherlands according to type of histology. Available from: http://cijfersoverkanker.nl. Accessed March 30, 2021.
Netherlands Cancer Registry: Richtlijn niet-kleincellig longcarcinoom. Published 2004. Updated June 3, 2020. Available from: http://cijfersoverkanker.nl. Accessed March 30, 2021.
- ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).Eur Respir J. 2009; 34: 17-41
- Incidence of non-small cell lung cancer in The Netherlands in 2021 according to 5-year age groups Available from.http://cijfersoverkanker.nlDate accessed: October 31, 2022
- Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer.Thorax. 2004; 59: 602-607
- The outcome of combined-modality therapy for stage III non–small-cell lung cancer in the elderly.J Clin Oncol. 2003; 21: 3201-3206
- Stage III Non-Small Cell Lung Cancer in the elderly: patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice.Radiother Oncol. 2016; 121: 26-31
- The ability of prehabilitation to influence postoperative outcome after intra-abdominal operation: a systematic review and meta-analysis.Surgery. 2016; 160: 1189-1201
- Effects of lung rehabilitation therapy in improving respiratory motor ability and alleviating dyspnea in patients with lung cancer after lobectomy: a clinical study.Alternative Ther Health Med. 2020; 28: 18-23
- Effect of postsurgical rehabilitation programmes in patients operated for lung cancer: a systematic review and meta-analysis.J Rehabil Med. 2018; 50: 236-245
- Self-efficacy, cancer-related fatigue, and quality of life in patients with resected lung cancer.Eur J Cancer Care. 2018; 27e12934
- Preoperative exercise halves the postoperative complication rate in patients with lung cancer: a systematic review of the effect of exercise on complications, length of stay and quality of life in patients with cancer.Br J Sports Med. 2018; 52: 344
- Effects of prehabilitation and rehabilitation including a home-based component on physical fitness, adherence, treatment tolerance, and recovery in patients with non-small cell lung cancer: a systematic review.Crit Rev Oncol Hematol. 2017; 114: 63-76
- Exercise training for patients pre- and postsurgically treated for non-small cell lung cancer: a systematic review and meta-analysis.Integr Cancer Ther. 2017; 16: 63-73
- Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis.Thorax. 2021; 77: 486-496
- Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer.Cochrane Database Syst Rev. 2019; 6Cd009955
- Cochrane handbook for systematic reviews of interventions.second ed. John Wiley & Sons, Chichester (UK)2019
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.BMJ. 2016; 355: i4919
- i-CONTENT tool for assessing therapeutic quality of exercise programs employed in randomised clinical trials.Br J Sports Med. 2020; 55: 1153-1160
- Effects of presurgical exercise training on quality of life in patients undergoing lung resection for suspected malignancy: a pilot study.Cancer Nurs. 2009; 32: 158-165
- Preoperative exercise training prevents functional decline after lung resection surgery: a randomized, single-blind controlled trial.Clin Rehabil. 2017; 31: 1057-1067